ABT-510 is a molecular therapeutic drug used to treat cancer. According to the Journal of Clinical Oncology, ABT-510 is a "subcutaneously (SC) administered nonapeptide thrombospondin analogue in phase 2 clinical development for treatment of advanced malignancies."ABT-510 is an
angiogenesis inhibitor, meaning it works by stopping the growth of new blood vessels.
See more at Wikipedia.org...
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called angiogenesis inhibitors.